Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
India Thalassemia Market Research Report - Forecast to 2032
... an abnormal kind of haemoglobin. It causes a huge number of blood cells to be destroyed, resulting in anaemia. Thalassemia is a genetic condition caused by the deletion or modification of a specific gene segment. ... Read More
-
India Sickle Cell Anaemia Market Research Report Forecast to 2032
... disorder characterized by the presence of abnormal hemoglobin that causes red blood cells to become rigid and sickle shaped. It happens due to a mutation on the sixth position of the beta chain of hemoglobin ... Read More
-
Hemophilia B - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
2024 Global Forecast for Plasma Fractionation Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Rare Hemophilia Factors Databank Market Report
... 2021 to 2029. Factor II segment is expected to be the highest contributor to this market, with $1,123.8 Million in 2020, and is anticipated to reach $1,801.8 Million by 2029, registering a CAGR of 5.44%. ... Read More
-
Global Hematologic Malignancies Databank Market Report
... 2029. Leukemia segment is expected to be the highest contributor to this market, with $13,172.5 Million in 2020, and is anticipated to reach $25,934.9 Million by 2029, registering a CAGR of 7.87%. Lymphoma segment is ... Read More
-
Global Hemophilia Gene Therapy Market Analysis and Forecast 2024-2030
... genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals ... Read More
-
Global Hemophilia Gene Therapy Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood ... Read More
-
Global Hemophilia Gene Therapy Market Size, Manufacturers, Opportunities and Forecast to 2030
... caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels ... Read More
-
Global Hemophilia Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and ... Read More
-
Hemophilia Gene Therapy Industry Research Report 2024
... in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia ... Read More
-
Dual Chamber Prefilled Syringes Market, By Product Type (Conventional Prefilled Syringes, Safety Prefilled Syringes), By Material Type (Glass and Plastic), By Indication (Hemophilia, Schizophrenia, Diabetes, Erectile Dysfunction, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Dual chamber prefilled syringes are medical devices that are used for delivering two separate pharmaceutical compounds or drugs in a ... Read More
-
Global Thalassemia Market - 2024-2031
... 2024-2031. Thalassemia represents a substantial health burden, particularly in regions where the prevalence is high. Individuals with severe forms of thalassemia require lifelong medical care, including blood transfusions, iron chelation therapy, and management of complications ... Read More
-
Biosimilars Market Size, Trends, Analysis, and Outlook By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Blood Disorders, Growth Hormonal Deficiency, Rheumatoid Arthritis, Chronic & Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... 2024-2032 The global Biosimilars market size is poised to register 12.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosimilars market across ... Read More
-
Global chemotherapy-induced thrombocytopenia Market - 2023-2030
... forecast period 2023-2030. Chemotherapy-induced thrombocytopenia (CIT) is characterized by a decreased platelet count in the blood as a result of chemotherapy treatment. Because platelets are necessary for blood clotting, a drop in their number can ... Read More
-
Hemophilia A - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Anemia Associated with Chronic Kidney - Pipeline Insight, 2024
... growth prospects across the Anemia Associated with Chronic Kidney market. A detailed picture of the Anemia Associated with Chronic Kidney pipeline landscape is provided, which includes the disease overview and Anemia Associated with Chronic Kidney ... Read More
-
Global Anemia Treatment Drugs Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Anemia Treatment Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Alpha Thalassemia Treatment Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Alpha Thalassemia Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Acquired Hemophilia Treatment Global Market Report 2024
... Bristol-Myers Squibb Company Acquired Hemophilia Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on ... Read More
-
Global Iron Deficiency Anemia Drug Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Iron Deficiency Anemia Drug is forecast to a readjusted size of US$ 2372.1 million by 2030 with a CAGR of 5.2% during review period. The research report highlights ... Read More
-
Renal Anemia Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Intravenous, Oral), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... size is poised to register 8.26% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Renal Anemia Therapeutics market By Type (Intravenous, ... Read More
-
Stem Cell Umbilical Cord Blood Market Size, Trends, Analysis, and Outlook By Storage Serivces (Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks), By Therapeutics (Cancer, Diabetes, Blood diseases, Immune Disorders, Metabolic Disorders, Others), By Application (Transplant Medicine, Regenerative Medicine), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), By Application (Transplant Medicine, Regenerative Medicine), by Region, Country, Segment, and Companies, 2024-2030 The global Stem Cell Umbilical Cord Blood market size is poised to register 9.8% growth (CAGR) from 2024 to 2030, ... Read More
-
Thalassemia Drugs Market Size, Trends, Analysis, and Outlook By Type (Alpha Thalassemia Drugs, Beta Thalassemia Drugs), By Treatment (Iron Chelation Therapy, Others), By Distribution Channel (Hospital Pharmacies, Online Providers, Retail Pharmacies, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Thalassemia Drugs market size is poised to register 7.03% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes ... Read More
-
Anemia Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Iron Deficiency Anemia, Sickle Cell Anemia, Pernicious Anemia, Hemolytic Anemia), By Application (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Therapeutics market size is poised to register 7.47% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Anemia Therapeutics market By Type ... Read More
Research Assistance
